Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2777-2785
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2777
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2777
Factor | Wald | P value | HR | 95%CI |
Gender | 2.527 | 0.112 | 1.723 | 0.881-3.369 |
Age | 1.799 | 0.180 | 0.659 | 0.359-1.212 |
Clinical stage | 41.852 | < 0.001 | ||
Clinical stage (1) | 37.267 | < 0.001a | 0.050 | 0.019-0.131 |
Clinical stage (2) | 22.155 | < 0.001a | 0.172 | 0.083-0.358 |
Surgery | 0.474 | 0.491 | 0.777 | 0.378-1.595 |
Chemotherapy cycles | 0.069 | 0.793 | 1.083 | 0.597-1.966 |
Radiotherapy | 0.581 | 0.446 | 1.386 | 0.599-3.209 |
Application of EAALs | 7.819 | 0.005a | 2.249 | 1.274-3.969 |
- Citation: Zhang GQ, Zhao H, Wu JY, Li JY, Yan X, Wang G, Wu LL, Zhang XG, Shao Y, Wang Y, Jiao SC. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy. World J Gastroenterol 2015; 21(9): 2777-2785
- URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2777.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2777